Precision Biosciences (DTIL) Accumulated Depreciation & Amortization (2018 - 2024)
Historic Accumulated Depreciation & Amortization for Precision Biosciences (DTIL) over the last 7 years, with Q4 2024 value amounting to $28.1 million.
- Precision Biosciences' Accumulated Depreciation & Amortization rose 1015.38% to $28.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.1 million, marking a year-over-year increase of 1015.38%. This contributed to the annual value of $28.1 million for FY2024, which is 1015.38% up from last year.
- Per Precision Biosciences' latest filing, its Accumulated Depreciation & Amortization stood at $28.1 million for Q4 2024, which was up 1015.38% from $25.5 million recorded in Q4 2023.
- Precision Biosciences' Accumulated Depreciation & Amortization's 5-year high stood at $28.1 million during Q4 2024, with a 5-year trough of $19.1 million in Q4 2020.
- Over the past 5 years, Precision Biosciences' median Accumulated Depreciation & Amortization value was $23.9 million (recorded in 2021), while the average stood at $23.7 million.
- As far as peak fluctuations go, Precision Biosciences' Accumulated Depreciation & Amortization surged by 7915.3% in 2020, and later plummeted by 855.15% in 2022.
- Precision Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $19.1 million in 2020, then grew by 25.35% to $23.9 million in 2021, then decreased by 8.55% to $21.9 million in 2022, then increased by 16.55% to $25.5 million in 2023, then rose by 10.15% to $28.1 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $28.1 million for Q4 2024, versus $25.5 million for Q4 2023 and $21.9 million for Q4 2022.